antibodydepend
enhanc
ade
occur
antibodi
facilit
viral
entri
host
cell
enhanc
viral
infect
cell
ade
observ
varieti
virus
notabl
flavivirus
eg
dengu
viru
shown
patient
infect
one
serotyp
dengu
viru
ie
primari
infect
produc
neutral
antibodi
target
serotyp
viru
howev
later
infect
anoth
serotyp
dengu
viru
ie
secondari
infect
preexist
antibodi
fulli
neutral
viru
instead
antibodi
first
bind
viru
bind
igg
fc
receptor
immun
cell
mediat
viral
entri
cell
similar
mechan
observ
hiv
ebola
virus
thu
subneutr
antibodi
nonneutr
antibodi
case
respons
ade
virus
given
critic
role
antibodi
host
immun
ade
caus
seriou
concern
epidemiolog
vaccin
design
antibodybas
drug
therapi
studi
reveal
novel
mechan
ade
fulli
neutral
antibodi
mimic
function
viral
receptor
mediat
viral
entri
fc
receptorexpress
cell
coronavirus
famili
larg
positivestrand
envelop
rna
virus
two
highli
pathogen
coronavirus
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
caus
lethal
infect
human
envelopeanchor
spike
protein
guid
coronaviru
entri
host
cell
homotrim
spike
contain
three
receptorbind
subunit
trimer
membran
fusion
stalk
state
spike
matur
virion
call
prefus
sarscov
merscov
recogn
angiotensinconvert
enzym
dipeptidyl
peptidas
respect
viral
receptor
subunit
contain
receptorbind
domain
rbd
mediat
receptor
recognit
fig
rbd
locat
tip
spike
trimer
present
two
differ
state
stand
lie
fig
bind
viral
receptor
stabil
rbd
standingup
state
receptor
bind
also
trigger
spike
undergo
conform
chang
allow
host
proteas
cleav
two
site
sequenti
first
boundari
ie
site
within
ie
site
proteolysi
spike
take
place
viral
matur
proprotein
convertas
viral
releas
extracellular
proteas
viral
attach
cell
surfac
proteas
viral
endocytosi
lysosom
proteas
two
proteas
cleavag
dissoci
undergo
dramat
structur
chang
fuse
host
viral
membran
membran
fusion
state
spike
call
postfus
due
recent
progress
toward
understand
receptor
recognit
membran
fusion
mechan
coronaviru
spike
coronavirus
repres
excel
model
system
investig
ade
viral
entri
ade
observ
coronavirus
sever
studi
shown
sera
induc
sarscov
spike
enhanc
viral
entri
fc
receptorexpress
cell
one
studi
demonstr
unlik
receptordepend
viral
entri
serumdepend
sarscov
entri
go
endosom
pathway
addit
long
known
immun
cat
felin
coronaviru
spike
lead
worsen
futur
infect
due
induct
infectionenhanc
antibodi
howev
detail
molecular
mechan
ade
coronaviru
entri
still
unknown
previous
discov
monoclon
antibodi
mab
name
strong
bind
affin
merscov
rbd
effici
neutral
merscov
entri
outcompet
discoveri
allow
us
compar
studi
molecular
mechan
antibodydepend
receptordepend
viral
entri
studi
examin
bind
merscov
spike
trigger
spike
undergo
conform
chang
mediat
viral
entri
fc
receptorexpress
cell
also
investig
pathway
antibodi
dosag
viral
entri
studi
shed
light
mechan
ade
provid
insight
vaccin
design
antibodybas
antivir
drug
therapi
investig
ade
coronaviru
entri
first
character
interact
merscov
rbdspecif
mab
merscov
spike
use
biochem
method
first
enzymelink
immunosorb
assay
elisa
perform
merscov
rbd
merscov
spike
ectodomain
se
fig
end
excess
use
coat
elisa
plate
gradient
amount
recombin
rbd
se
ad
detect
potenti
bind
result
show
rbd
se
bound
se
bound
tightli
rbd
like
due
multival
effect
associ
trimer
state
se
second
prepar
fab
use
papain
digest
examin
bind
fab
se
use
elisa
recombin
se
excess
use
coat
elisa
plate
gradient
amount
fab
ad
detect
potenti
bind
se
result
show
fab
bound
se
fig
bound
se
tightli
fab
also
like
due
multival
effect
associ
dimer
state
third
flow
cytometri
assay
carri
detect
bind
se
receptor
among
se
fc
receptor
end
express
surfac
human
cell
human
kidney
cell
recombin
se
ad
detect
potenti
bind
one
two
receptor
absenc
presenc
result
show
without
se
bound
presenc
se
bound
fig
neg
control
sarscov
rbdspecif
mab
mediat
bind
se
cell
surfac
express
measur
use
calibr
flow
cytometri
result
fig
demonstr
direct
bind
se
stronger
indirect
bind
se
overal
biochem
result
reveal
directli
bind
rbd
region
merscov
se
also
mediat
indirect
bind
interact
merscov
se
fc
receptor
next
investig
whether
mediat
merscov
entri
fc
receptorexpress
cell
end
perform
merscov
pseudoviru
entri
assay
retrovirus
pseudotyp
merscov
spike
ie
merscov
pseudovirus
use
enter
human
cell
express
surfac
main
advantag
pseudoviru
entri
assay
focu
viral
entri
step
mediat
merscov
spike
separ
viral
entri
step
viral
infect
cycl
eg
replic
packag
releas
test
three
differ
type
fc
receptor
fc
receptor
exogen
express
cell
also
test
macrophag
mixtur
fc
receptor
endogen
express
absenc
serv
control
nonneutr
mab
would
appropri
anoth
control
access
nonneutr
mab
result
show
absenc
merscov
pseudovirus
could
enter
fc
receptorexpress
cell
presenc
merscov
pseudovirus
demonstr
signific
effici
enter
cell
macrophag
fig
comparison
absenc
merscov
pseudovirus
enter
cell
effici
entri
block
effect
fig
control
experi
antisar
mab
mediat
merscov
pseudoviru
entri
fc
receptorexpress
cell
macrophag
block
merscov
pseudoviru
entri
receptorexpress
cell
fig
anoth
set
control
experi
show
neither
fc
fab
portion
could
mediat
merscov
pseudoviru
entri
fc
receptorexpress
cell
macrophag
fig
suggest
fc
fab
portion
antim
mab
requir
antibodymedi
viral
entri
abovement
cell
induc
exogen
express
high
level
detect
background
express
level
perform
revers
transcriptionquantit
pcr
qrtpcr
cell
result
show
cell
express
low
level
fig
comparison
cell
human
lung
cell
express
high
level
wherea
hela
cell
human
cervic
cell
express
fig
comprehens
control
experi
perform
low
endogen
express
cell
affect
conclus
nevertheless
confirm
result
use
hela
cell
express
fig
overal
result
reveal
mediat
merscov
entri
fc
receptorexpress
cell
block
merscov
entri
cell
expand
abovedescrib
observ
anoth
coronaviru
investig
ade
sarscov
entri
previous
identifi
sarscov
rbdspecif
mab
name
bind
region
sarscov
rbd
mab
examin
potenti
capabl
mediat
ade
sarscov
entri
fig
result
show
mediat
sarscov
pseudoviru
entri
cell
block
sarscov
pseudoviru
entri
cell
therefor
merscov
rbdspecif
mab
sarscov
rbdspecif
mab
mediat
entri
respect
coronaviru
fc
receptorexpress
human
cell
block
entri
respect
coronaviru
viralreceptorexpress
human
cell
remaind
studi
select
merscov
rbdspecif
mab
indepth
analysi
ade
understand
molecular
mechan
ade
investig
whether
trigger
conform
chang
merscov
spike
shown
previous
bind
merscov
spike
stabil
rbd
standingup
posit
fig
b
result
weaken
spike
structur
allow
site
becom
expos
proteas
repeat
experi
merscov
pseudovirus
incub
subject
trypsin
cleavag
fig
result
show
viral
packag
process
viru
surfaceanchor
merscov
spike
molecul
cleav
site
proprotein
convertas
absenc
spike
molecul
could
cleav
site
trypsin
data
suggest
site
site
access
proteas
free
form
spike
trimer
presenc
signific
amount
merscov
spike
molecul
cleav
site
trypsin
indic
bind
trigger
conform
chang
merscov
spike
expos
site
interestingli
found
bind
also
allow
merscov
spike
cleav
site
trypsin
neg
control
sarscov
rbdspecif
mab
trigger
merscov
spike
cleav
site
trypsin
henc
like
trigger
conform
chang
merscov
spike
expos
site
proteolysi
analyz
bind
merscov
se
use
negativestain
electron
microscopi
em
previous
demonstr
mutagenesi
studi
bind
receptorbind
region
merscov
rbd
fig
fulllength
dimer
trigger
aggreg
se
trimer
prepar
fab
part
monom
detect
bind
fab
se
fig
use
fab
negativestain
em
studi
result
show
fab
bound
tip
se
trimer
rbd
locat
fig
due
limit
resolut
negativestain
em
could
clearli
see
conform
fabbound
rbd
howev
base
previou
studi
receptorbind
site
rbd
spike
trimer
access
rbd
standingup
posit
henc
fact
mab
bind
receptorbind
region
rbd
spike
trimer
suggest
rbd
standingup
state
thu
result
negativestain
em
proteolysi
studi
consist
support
idea
like
stabil
rbd
standingup
posit
trigger
conform
chang
spike
futur
studi
highresolut
cryoem
structur
merscov
se
trimer
complex
need
provid
detail
structur
inform
conform
chang
merscov
se
understand
pathway
merscov
entri
evalu
potenti
impact
differ
proteas
merscov
pseudoviru
entri
proteas
distribut
along
viral
entri
pathway
first
proprotein
convertas
inhibitor
ppci
use
examin
role
proprotein
convertas
matur
merscov
spike
impact
proprotein
convertas
ensu
viral
entri
fig
result
show
merscov
pseudovirus
produc
cell
presenc
ppci
cleavag
merscov
spike
proprotein
convertas
significantli
inhibit
fig
absenc
merscov
pseudovirus
packag
presenc
ppci
enter
human
cell
effici
packag
absenc
ppci
fig
presenc
merscov
pseudovirus
packag
presenc
ppci
enter
cell
effici
packag
absenc
ppci
fig
data
suggest
proprotein
convertas
play
role
albeit
drastic
proteas
see
merscov
entri
second
cell
surfac
proteas
transmembran
serin
proteas
introduc
human
cell
evalu
role
viral
entri
fig
result
show
absenc
enhanc
merscov
pseudoviru
entri
cell
consist
previou
report
presenc
also
enhanc
merscov
pseudoviru
entri
cell
suggest
activ
merscov
entri
third
lysosom
proteas
inhibitor
evalu
role
lysosom
proteas
viral
entri
fig
two
inhibitor
use
lysosom
acidif
inhibitor
cystein
proteas
inhibitor
result
show
lysosom
proteas
inhibitor
block
viral
entri
pathway
consist
previou
report
lysosom
proteas
inhibitor
also
block
viral
entri
pathway
suggest
lysosom
proteas
play
import
role
merscov
entri
taken
togeth
merscov
entri
activ
proprotein
convertas
cell
surfac
proteas
lysosom
proteas
henc
pathway
share
merscov
entri
determin
rang
dosag
ade
merscov
pseudoviru
entri
perform
presenc
differ
concentr
three
type
human
cell
use
cell
exogen
express
accordingli
three
differ
set
result
obtain
first
amount
increas
viral
entri
cell
continu
drop
fig
result
reveal
block
viral
entri
pathway
outcompet
bind
merscov
spike
second
amount
increas
viral
entri
cell
first
increas
decreas
fig
turn
point
ngml
like
explan
result
follow
low
concentr
mab
molecul
enhanc
indirect
interact
merscov
spike
fc
receptor
high
concentr
mab
molecul
satur
cell
surfac
fc
receptor
molecul
bind
merscov
spike
block
indirect
interact
merscov
spike
fc
receptor
third
amount
increas
viral
entri
cell
express
first
drop
increas
final
drop
fig
result
cumul
effect
previou
two
result
reveal
present
host
cell
surfac
inhibit
viral
entri
block
entri
pathway
low
concentr
promot
viral
entri
enhanc
entri
pathway
intermedi
concentr
inhibit
viral
entri
block
entri
pathway
high
concentr
confirm
abovedescrib
result
use
cell
human
lung
cell
endogen
express
fig
therefor
ade
merscov
entri
depend
rang
dosag
well
express
viral
fc
receptor
cell
surfac
ade
viral
entri
observ
studi
extens
flavivirus
particularli
dengu
viru
also
observ
hiv
ebola
virus
virus
propos
primari
viral
infect
host
led
product
antibodi
subneutr
nonneutr
secondari
viral
infect
antibodi
complet
neutral
secondari
viral
infect
instead
guid
viru
particl
enter
fc
receptorexpress
cell
ade
lead
worsen
symptom
secondari
viral
infect
caus
major
concern
epidemiolog
ade
also
major
concern
vaccin
design
antibodybas
drug
therapi
sinc
antibodi
gener
use
procedur
may
lead
ade
ade
observ
coronavirus
decad
molecular
mechan
unknown
recent
advanc
understand
receptor
recognit
cell
entri
mechan
coronavirus
allow
us
use
coronavirus
model
system
studi
ade
studi
first
demonstr
merscov
rbdspecif
neutral
mab
bind
rbd
region
merscov
spike
show
mab
mediat
merscov
pseudoviru
entri
fc
receptorexpress
human
cell
moreov
sarscov
rbdspecif
neutral
mab
mediat
ade
sarscov
pseudoviru
entri
result
demonstr
ade
coronavirus
mediat
neutral
mab
target
rbd
coronaviru
spike
addit
coronaviru
strain
led
product
fulli
neutral
mab
mediat
go
ade
neutral
mab
result
differ
previous
observ
ade
flavivirus
primari
infect
secondari
infect
caus
two
differ
viral
strain
ademedi
mab
subneutr
nonneutr
secondari
viral
infect
therefor
studi
expand
concept
ade
viral
entri
examin
molecular
mechan
ade
coronaviru
entri
show
mab
bind
tip
merscov
spike
trimer
rbd
locat
mab
bind
like
stabil
rbd
standingup
posit
trigger
conform
chang
merscov
spike
expos
previous
inaccess
site
proteas
prepar
manuscript
newli
publish
studi
demonstr
sarscov
rbdspecif
mab
name
bound
region
sarscov
rbd
stabil
rbd
standingup
posit
trigger
conform
chang
sarscov
spike
fig
contrast
merscov
rbdspecif
mab
name
bound
side
merscov
rbd
away
region
stabil
rbd
lyingdown
posit
trigger
conform
chang
merscov
spike
fig
publish
result
consist
result
regard
conform
chang
merscov
spike
togeth
suggest
order
trigger
conform
chang
coronaviru
spike
mab
need
bind
receptorbind
region
rbd
stabil
rbd
standingup
posit
moreov
studi
reveal
ade
merscov
entri
follow
entri
pathway
merscov
entri
specif
proprotein
convertas
partial
activ
merscov
spike
cell
surfac
proteas
present
merscov
spike
activ
fuse
membran
cell
surfac
otherwis
merscov
enter
endosom
lysosom
lysosom
proteas
activ
merscov
spike
membran
fusion
taken
togeth
result
show
rbdspecif
neutral
mab
bind
region
coronaviru
spike
viral
receptor
trigger
conform
chang
spike
viral
receptor
mediat
ade
pathway
viralreceptordepend
viral
entri
word
rbdspecif
neutral
mab
mediat
ade
coronaviru
entri
function
mimick
viral
receptor
final
analyz
ade
coronaviru
entri
differ
antibodi
dosag
merscov
entri
cell
express
viral
fc
receptor
demonstr
complex
mabdosagedepend
pattern
concentr
mab
increas
viral
entri
cell
inhibit
effici
mab
bind
spike
block
entri
pathway
ii
viral
entri
fc
receptorexpress
cell
first
enhanc
inhibit
mab
bind
fc
receptor
enhanc
ade
pathway
fc
receptor
molecul
satur
iii
viral
entri
cell
express
fc
receptor
first
inhibit
enhanc
final
inhibit
cumul
effect
previou
two
pattern
word
viral
entri
cell
express
fc
receptor
exist
balanc
antibodydepend
entri
pathway
shift
determin
mab
dosag
importantli
ade
occur
intermedi
mab
dosag
studi
explain
earlier
observ
ade
dengu
virus
occur
certain
concentr
mab
mani
human
tissu
express
either
fc
receptor
notabl
placenta
express
virus
use
viral
receptor
differ
may
also
human
tissu
viral
receptor
fc
receptor
express
express
level
two
receptor
specif
tissu
cell
like
determin
mab
dosag
ade
would
occur
tissu
determin
adeen
mab
dosag
may
includ
bind
affin
mab
viral
fc
receptor
overal
studi
suggest
ade
virus
depend
antibodi
dosag
tissuespecif
express
viral
fc
receptor
intrins
featur
antibodi
find
reveal
novel
molecular
mechan
ade
coronavirus
also
provid
gener
guidelin
viral
vaccin
design
antibodybas
antivir
drug
therapi
shown
rbdspecif
neutral
mab
may
mediat
ade
virus
mimick
function
viral
receptor
neutral
mab
target
part
viral
spike
would
less
like
mediat
ade
trigger
conform
chang
spike
henc
reduc
likelihood
ade
spikebas
subunit
vaccin
lack
rbd
design
prevent
viral
infect
base
principl
neutral
mab
target
part
spike
select
treat
viral
infect
moreov
alreadi
discuss
studi
stress
import
choos
antibodi
dosag
caus
ade
point
differ
tissu
cell
close
monitor
potenti
ade
certain
antibodi
dosag
vitro
system
use
studi
provid
model
framework
ade
futur
research
use
vivo
system
need
confirm
result
previou
studi
show
human
version
effici
protect
human
mice
live
merscov
challeng
suggest
given
antibodi
dosag
use
previou
studi
well
bind
affin
mab
human
receptordepend
pathway
merscov
entri
domin
ade
vivo
thu
futur
vivo
studi
may
need
screen
wide
rang
antibodi
dosag
also
varieti
tissu
differ
ratio
fc
receptor
express
although
ade
observ
merscov
vivo
studi
suggest
ade
occur
specif
condit
vivo
depend
antibodi
dosag
bind
affin
mab
tissu
express
fc
receptor
moreov
mechan
identifi
ade
merscov
vitro
may
account
ade
observ
vivo
coronavirus
sarscov
felin
coronaviru
overal
studi
reveal
complex
role
antibodi
viral
entri
guid
futur
vaccin
design
antibodybas
drug
therapi
cell
cell
human
embryon
kidney
cell
hela
cell
human
cervic
cell
cell
human
lung
cell
obtain
american
type
cultur
collect
atcc
chain
cell
human
embryon
kidney
cell
construct
previous
cell
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
mm
lglutamin
uml
penicillin
streptomycin
cell
human
macrophag
obtain
atcc
cultur
rpmi
cultur
medium
invitrogen
contain
heatinactiv
fb
supplement
mm
hepe
mm
pyruv
gliter
dglucos
pm
streptomycin
induct
macrophag
human
monocyt
cell
treat
nm
phorbol
h
follow
h
incub
rpmi
medium
experi
fulllength
gene
merscov
spike
genbank
access
number
sarscov
spike
genbank
access
number
human
genbank
access
number
human
genbank
access
number
synthes
genscript
biotech
three
fc
receptor
gene
human
genbank
access
number
human
genbank
access
number
human
genbank
access
number
clone
previous
protein
express
cell
surfac
pseudoviru
surfac
abovenam
gene
subclon
vector
life
technolog
ctermin
tag
elisa
negativestain
electron
microscop
studi
recombin
merscov
spike
ectodomain
se
prepar
merscov
se
residu
subclon
pcmv
vector
contain
ctermin
trimer
tag
tag
stabil
se
prefus
conform
follow
procedur
previou
studi
introduc
mutat
proteas
cleavag
site
region
merscov
se
express
cell
use
freestyl
mammalian
cell
express
system
life
technolog
briefli
cell
transfect
plasmid
encod
merscov
se
cultur
day
protein
harvest
cell
cultur
medium
purifi
sequenti
nickelnitrilotriacet
aid
ninta
column
gel
filtrat
column
ge
healthcar
store
buffer
contain
mm
tri
ph
mm
nacl
ectodomain
human
express
purifi
previous
describ
briefli
ectodomain
residu
contain
ntermin
human
signal
peptid
ctermin
tag
express
insect
cell
use
bactobac
express
system
life
technolog
secret
cell
cultur
medium
purifi
way
merscov
se
merscov
rbdspecif
mab
ie
sarscov
rbdspecif
mab
ie
purifi
previous
describ
briefli
hybridoma
cell
express
mab
inject
abdomen
mice
day
mous
ascit
contain
mab
collect
mab
purifi
use
protein
column
ge
healthcar
fab
antibodi
prepar
use
immobil
papain
bead
thermo
fisher
scientif
accord
manufactur
manual
briefli
antibodi
incub
immobil
papain
bead
digest
buffer
mm
sodium
phosphat
mm
edta
mm
lcystein
hcl
ph
shake
water
bath
overnight
digest
reaction
stop
mm
tri
hcl
ph
supernat
collect
centrifug
g
min
fab
separ
undigest
igg
fc
use
protein
column
ge
healthcar
bind
affin
mab
merscov
se
rbd
measur
use
elisa
previous
describ
briefli
elisa
plate
precoat
mab
nm
h
block
bovin
serum
albumin
bsa
h
merscov
se
rbd
nm
gradient
concentr
specifi
fig
ad
plate
incub
mab
h
wash
phosphatebuff
salin
pb
plate
incub
antibodi
santa
cruz
h
plate
wash
pb
incub
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
antibodi
h
wash
pb
enzymat
reaction
carri
use
elisa
substrat
life
technolog
stop
absorb
nm
measur
use
tecan
infinit
pro
micropl
reader
tecan
group
ltd
five
replic
done
sampl
pb
use
neg
control
flow
cytometri
perform
previous
describ
briefli
cell
exogen
express
one
fc
receptor
incub
merscov
se
mab
contain
ctermin
tag
room
temperatur
min
follow
incub
fluorescein
phycoerythrin
pe
label
probe
antibodi
anoth
min
cell
analyz
use
fluorescenceactiv
cell
sort
fac
coronaviru
spikemedi
pseudoviru
entri
assay
carri
previous
describ
briefli
pseudoviru
packag
cell
cotransfect
plasmid
carri
envdefect
luciferaseexpress
hiv
type
genom
plasmid
encod
merscov
sarscov
spike
pseudovirus
harvest
purifi
use
sucros
gradient
ultracentrifug
g
h
transfect
use
enter
target
cell
detect
pseudoviru
entri
pseudovirus
cell
incub
h
medium
chang
cell
incub
addit
h
cell
wash
pb
lyse
aliquot
cell
lysat
transfer
perkinelm
follow
addit
luciferas
substrat
rel
light
unit
rlu
measur
use
enspir
plate
reader
perkinelm
measur
carri
four
replic
inhibit
proprotein
convertas
packag
merscov
pseudovirus
nm
proprotein
convertas
inhibitor
ppci
decrvkrcmk
enzo
life
scienc
ad
cell
cultur
medium
h
posttransfect
packag
pseudovirus
purifi
describ
inhibit
pseudoviru
entri
use
variou
proteas
inhibitor
carri
describ
previous
briefli
cell
pretreat
nm
proprotein
convertas
inhibitor
decrvkrcmk
enzo
life
scienc
nm
camostat
mesyl
sigmaaldrich
nm
bafilomycin
sigmaaldrich
nm
sigmaaldrich
h
ngml
antibodi
min
abovedescrib
cell
use
pseudoviru
entri
assay
examin
express
level
receptor
protein
cell
membran
cell
express
receptor
harvest
membraneassoci
protein
extract
use
membran
protein
extract
kit
thermo
fisher
scientif
briefli
cell
centrifug
g
min
wash
cell
wash
solut
twice
cell
pellet
resuspend
ml
permeabil
buffer
incub
min
supernat
contain
cytosol
protein
remov
centrifug
g
min
pellet
contain
membraneassoci
protein
resuspend
ml
solubil
buffer
incub
min
centrifug
g
min
membraneassoci
protein
supernat
transfer
new
tube
express
level
membraneassoci
receptor
protein
among
membraneassoci
protein
measur
use
western
blot
analysi
use
normal
result
flow
cytometri
cellbind
assay
pseudoviru
entri
assay
total
rna
cell
extract
use
trizol
reagent
accord
manufactur
manual
briefli
trizol
ad
cell
lysat
chloroform
phenolchloroform
ad
precipit
rna
rna
pellet
wash
use
ethanol
solubil
diethyl
pyrocarbon
depc
treat
water
revers
transcrib
use
murin
leukemia
viru
mlv
revers
transcriptas
promega
oligo
dt
primer
promega
quantit
pcr
rna
perform
use
primer
sybr
qpcr
kit
biorad
cfx
qpcr
instrument
biorad
dehydrogenas
gapdh
rna
use
control
primer
follow
forward
revers
gapdh
forward
revers
purifi
merscov
pseudovirus
incub
recombin
mab
pb
min
treat
mgml
tosylsulfonyl
phenylalanyl
chloromethyl
keton
tpck
treat
trypsin
ice
min
sampl
subject
western
blot
merscov
spike
cleav
fragment
contain
ctermin
tag
detect
use
tag
monoclon
antibodi
santa
cruz
biotechnolog
sampl
dilut
final
concentr
mgml
pb
load
onto
glowdischarg
carbon
grid
electron
microscopi
scienc
grid
stain
uranyl
format
micrograph
acquir
use
tecnai
spirit
biotwin
kev
fei
compani
eagl
chargecoupleddevic
ccd
camera
nomin
magnif
univers
minnesota
